Plasma-derived product · Protein replacement · developed by Biotest
Phase 3Most advanced trial (none active)
1Registered trials
What is BT524?
BT524 is a human fibrinogen concentrate given by intravenous infusion, with dosing based on body weight and fibrinogen level. It is studied in congenital afibrinogenemia and congenital hypofibrinogenemia, conditions in which patients lack or have low levels of fibrinogen.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.